BeAble Capital Research
Investment Thesis
BeAble Capital is a Madrid-based venture manager that describes itself as a science equity investor. It backs deep-science companies that turn research from Spanish universities, research centers and technology transfer offices into industrial start-ups. Its stated mission is to tackle the United Nations Sustainable Development Goals. Selection rests on the scientific research behind a company, its intellectual property and the competing technologies, judged from both a scientific and a market view. The firm looks for disruptive technologies with lasting advantages based on IP and know-how, aimed at unmet needs in fast-growing markets.
Sector Focus
BeAble invests in science-based companies in these areas:
- New Space
- New Energy
- New Materials
- Agro and Food
- Environment
- Healthcare and Wellbeing
- Medtech
- Robotics and AI
Portfolio companies include nanosatellites (Alen Space), batteries (BattBelt), biogas cleaning materials (Klin Loop), microplastics detection and removal (Captoplastic), biofabricated leather (Next-Gen Leather), biopolymers (DAN*NA), anti-counterfeiting inks (Molecular Gate), continuous fiber 3D printing (Reinforce 3D), photonics (Alcyono Photonics) and musculoskeletal health monitoring (Dawako).
Stage Focus
The firm invests at seed and early stage. It funds the first phases of an industrial start-up: proof of concept, scale-up, pilot plant or prototype, flagship and pre-industrial phases, and market launch. After those phases, it expects companies to be financed by later-stage venture capital or private equity investors.
Check Size
BeAble does not publish a standard check size. Recent rounds it led were small to mid-sized: EUR 630,000 in BattBelt (late 2025), EUR 750,000 in BIOM (2025) and EUR 2 million in Captoplastic (2025).
Lead Tendency
The firm often leads. Press coverage describes it as leading the BattBelt, BIOM and Captoplastic rounds.
Recent Activity
- Led a EUR 630,000 round in BattBelt, a Basque start-up whose technology extends electric vehicle battery life by up to 50 percent (December 2025).
- Led a EUR 2 million round in Captoplastic, a microplastics removal start-up (June 2025).
- Led a EUR 750,000 round in BIOM, a bioinspired materials company (May 2025).
- Molecular Gate, an ICMAB-CSIC spin-off, is working with Avery Dennison to validate its anti-counterfeit polymer technology (November 2025).
Portfolio Highlights
The firm lists 18 portfolio companies: Next-Gen Leather, Alen Space, Klin Loop, Safeloc, Molecular Gate, ADP Cosmetics, BattBelt, Dawako, Captoplastic, Ceramik, Ecogranular, DAN*NA, Reinforce 3D, Alcyono Photonics, Inbentus Medical Technology, Aridditive, Calpech and BIOM. The firm does not publish exits.
Team
- Almudena Trigo, Partner and chairwoman of the fund
- David Lopez, Partner
- Roberto Ranera, Partner
- Alberto Diaz, Partner
Decision Process
Four partners run the firm and decide as a partnership. The firm builds close ties with universities, research centers, technology transfer offices and industrial companies to find projects, and it works on partnering, licensing and co-development globally.
Fund Backing
BeAble manages the BeAble Innvierte Kets Fund FCR, the BeAble Innvierte Science Equity Fund FCRE and the BeAble Science Equity Fund FCRE, all registered with the Spanish securities regulator. Backers include CDTI through Innvierte Economia Sostenible, ICO through FONDICO Global FCR, and the European Fund for Strategic Investment. Part of the financing comes from NextGenerationEU funds.
Founder Preferences
The firm backs scientist-led teams with strong IP, often university or research-center spin-offs, building hardware, materials or other industrial technology. It also supports the move from lab result to product through start-ups.
Geographic Focus
Deal flow is focused on Spain. The firm acts globally for partnering, licensing, co-development and commercial agreements. It is based at Calle Genova 11, Madrid. Contact is [email protected] or +34 91 702 26 82.